Publicación: Actual and potential drug interactions of psychotropic drugs in patients of the COVID-19 medicine service of the emergency hospital-Lima, 2021
| dc.contributor.author | Pairazamán, Ambrocio Teodoro Esteves | |
| dc.contributor.author | Caldas Herrera, Emma | |
| dc.contributor.author | Leon Apac, Gabriel | |
| dc.contributor.author | Collanque Pinto, Jesús Daniel | |
| dc.contributor.author | Caldas Herrera, María Evelina | |
| dc.contributor.author | Ñañez del Pino, Daniel | |
| dc.contributor.author | Martínez Carreras, Javier Francisco | |
| dc.contributor.author | Robles Huaranca, Ricardo | |
| dc.date.accessioned | 2025-09-05T16:36:44Z | |
| dc.description.abstract | Background: Actual and potential drug–drug interactions of psychotropic drugs in patients of the COVID-19 Medicine Service of the Villa El Salvador Emergency Hospital during the months of February to July, 2021. Methods: The study is deductive, retroprospective, quantitative, applied, cross-sectional observational. The instrument used was a collection card for 86 pharmacotherapeutic follow-ups where psychotropic drugs for anxiety, depression and insomnia were registered. Results: In the actual and potential drug interactions of psychotropic drugs, according to the degree of severity dimension, it was identified that the important indicator represented the highest frequency of 89% of the interactions; according to the type of interaction dimension, it was identified that the pharmacodynamic indicator presented a higher frequency with 53%; according to the clinical evidence dimension, it was identified that the fair indicator had a higher frequency with 73% interactions; in the manifestation dimension, it was identified that the potential indicator presented a higher frequency with 92.2% interactions. In its moment of appearance dimension, it was identified that the quick indicator had a higher prevalence with 5.5% of real interactions. In its causality algorithm dimension, the probable indicator was identified as having the highest frequency with 7.25% of actual interactions. With respect to sex, the male presented 49.9% of potential interactions and in the real interactions, the female sex presented a higher incidence with 4.3% interactions. The average age of the potential interactions was 48.83 years, and the average age of the real interactions was 45.67 years. Sertraline presented 53.2% of potential interactions and in relation to real drug interactions the one that presented the highest frequency was mirtazapine with 3.5% interactions. Conclusion: We conclude that the increase in the prescription of psychotropic drugs is related to a higher probability of interactions. © 2023 Elsevier B.V., All rights reserved. | |
| dc.identifier.doi | 10.12688/f1000research.121692.1 | |
| dc.identifier.scopus | 2-s2.0-85168585739 | |
| dc.identifier.uri | https://cris.uwiener.edu.pe/handle/001/806 | |
| dc.identifier.uuid | 5c45f8b0-6e09-466d-99b4-dddbe04c944c | |
| dc.language.iso | en | |
| dc.publisher | F1000 Research Ltd | |
| dc.relation.citationvolume | 11 | |
| dc.relation.ispartofseries | F1000Research | |
| dc.relation.issn | 20461402 | |
| dc.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.title | Actual and potential drug interactions of psychotropic drugs in patients of the COVID-19 medicine service of the emergency hospital-Lima, 2021 | |
| dc.type | http://purl.org/coar/resource_type/c_2df8fbb1 | |
| dspace.entity.type | Publication | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.affiliation.name | Universidad Privada Norbert Wiener | |
| person.identifier.orcid | 0000-0003-4168-0850 | |
| person.identifier.orcid | 0000-0003-1501-2090 | |
| person.identifier.orcid | 0000-0003-2855-1632 | |
| person.identifier.orcid | https://orcid.org/0000-0002-4955-8094 | |
| person.identifier.orcid | 0000-0002-9605-8594 | |
| person.identifier.orcid | 0000-0002-8491-2757 | |
| person.identifier.orcid | 0000-0002-2742-6744 | |
| relation.isAuthorOfPublication | bbee2e7b-2757-4382-aac2-2f8aa0847e72 | |
| relation.isAuthorOfPublication | 11d38815-c340-4f86-896e-6ea4b43f0556 | |
| relation.isAuthorOfPublication | 2995c599-cd70-489c-aca4-e43ba2940e74 | |
| relation.isAuthorOfPublication | 7726a0c2-bb0a-4d7e-84f5-04a30e44216c | |
| relation.isAuthorOfPublication | 87ab24e3-86eb-44ca-b2f6-bae246f34340 | |
| relation.isAuthorOfPublication | 7a75fd99-cb53-44a4-92fd-71cd60b6eecf | |
| relation.isAuthorOfPublication | 29ab5dfa-b505-4c37-8d3e-516820956415 | |
| relation.isAuthorOfPublication | a8cae2ac-3508-4124-b701-43aa18655c5f | |
| relation.isAuthorOfPublication.latestForDiscovery | bbee2e7b-2757-4382-aac2-2f8aa0847e72 |
